Targets, Technologies and Trials

The 2009 Gordon Conference on Tuberculosis Drug Development will cover the range of activities involved in producing new antibiotics. The conference will feature discussion of target and compound discovery, new potential antituberculous compounds in development, clinical trial design and early trial results and alternative approaches to tuberculosis treatment. We invite researchers interested in all of these aspects of drug development and welcome participants from academia, industry, government and non-governmental organizations. In particular, we invite trainees and scientists from developing countries to apply. All participants are asked to submit abstracts of their work for presentation as posters. Some abstracts will be chosen for oral presentations. The conference provides the opportunity to interact with colleagues in an informal and intimate atmosphere and is designed to promote the most possible discussion. The meeting has been oversubscribed in the past - please apply early!